Drug
Methyl Prednisolone (MP)
Methyl Prednisolone (MP) is a pharmaceutical drug with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 2 completed trials
Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
1
33%
Ph phase_1
1
33%
Ph phase_3
1
33%
Phase Distribution
1
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution3 total trials
Phase 1Safety & dosage
1(33.3%)
Phase 3Large-scale testing
1(33.3%)
N/ANon-phased studies
1(33.3%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
2 of 2 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Active(1)
Completed(2)
Detailed Status
Completed2
Enrolling by invitation1
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 11 (33.3%)
Phase 31 (33.3%)
N/A1 (33.3%)
Trials by Status
completed267%
enrolling_by_invitation133%
Recent Activity
0 active trials
Showing 3 of 3
enrolling_by_invitationphase_3
Comparing Methylprednisolone And Hyaluronic Acid To Reduce Wisdom Tooth Surgery Complications
NCT07317596
completedphase_1
Treatment of Familiar Lymphohistiocytosis
NCT02472054
completednot_applicable
Methylprednisolone vs Dexamethasone Interaction With Sugammadex in Pediatric Patients
NCT07175623
Clinical Trials (3)
Showing 3 of 3 trials
NCT07317596Phase 3
Comparing Methylprednisolone And Hyaluronic Acid To Reduce Wisdom Tooth Surgery Complications
NCT02472054Phase 1
Treatment of Familiar Lymphohistiocytosis
NCT07175623Not Applicable
Methylprednisolone vs Dexamethasone Interaction With Sugammadex in Pediatric Patients
All 3 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 3